Denali Therapeutics Inc (DNLI)
SG&A Expenses
$36.28M
Quarterly · Period ending: · USD
DNLI SG&A Expenses
Latest reported$36.28Mperiod ending
Latest reported$36.28Mperiod ending
DNLI Quarterly SG&A Expenses ($2.79M → $36.28M)
Quarterly SG&A Expenses
High-resolution chart · PNG
DNLI sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 36,283,000 | |
| 30,666,000 | |
| 36,594,000 | |
| 35,484,000 | |
| 32,267,000 | |
| 29,353,000 | |
| 30,059,000 | |
| 24,949,000 | |
| 25,194,000 | |
| 25,236,000 | |
| 24,769,000 | |
| 25,325,000 | |
| 26,120,000 | |
| 27,140,000 | |
| 23,516,000 | |
| 23,259,000 | |
| 21,159,000 | |
| 22,541,000 | |
| 21,759,000 | |
| 19,319,000 | |
| 19,045,000 | |
| 18,936,000 | |
| 17,994,000 | |
| 15,805,000 | |
| 13,972,000 | |
| 12,555,000 | |
| 10,879,000 | |
| 11,215,000 | |
| 15,076,000 | |
| 9,310,000 | |
| 11,045,000 | |
| 8,838,000 | |
| 6,896,000 | |
| 5,570,000 | |
| 5,069,000 | |
| 3,773,000 | |
| 3,564,000 | |
| 3,274,000 | |
| 3,046,000 | |
| 3,113,000 | |
| 2,786,000 | |
| 2,786,000 |